Skip to main content
. 2018 Nov 1;103(5):752–768. doi: 10.1016/j.ajhg.2018.10.006

Table 2.

Clinical Features in Indifviduals with NFIB Haploinsufficiency (Deletions)

Subject P8a P8b P9 P10a P10b P11 P12 P13 P14 P15 Summary All Subjects
Aberration 9p23p22.3 (14098659_14324147)x1 9p23p22.3 (14098659_14324147)x1 9p22.3p23 (14102175_14386038)x1 9p23p22.3 (13974415_14286259)x1 9p23p22.3 (13974415_14286259)x1 9p23p22.3 (13106806_14639971)x1 9p23p22.3 (13034407_14653394)x1 9p23p22.2 (14178768_16619009)x1 9p23p22.2 (13563537_18491752)x1 9p23p22.2 (13739630_18023839)x1
Deletion size 225 kb 225 kb 284 kb 312 kb 312 kb 1.5 Mb 1.6 Mb 2.4 Mb 4.9 Mb 4.3 Mb
Inheritance familial familial de novo de novo maternally inherited de novo unknown de novo de novo de novo
Sex F F M F F M M F M F
Age at last examination 6 y 8 y 7 y 20 y 3 y 5 m 8 y 4 m 21 y 7 y 10 m 10 y 17 y

Prenatal Growth >2 SDS

Birth weight (g) (SD) ND 3,470 (−0.1 SD; 54th) 3,500 (−0.10 SD; 46th) 4,400 (+2.13 SD; 98th) 3,400 (−0.05 SD;48th) 2,750 (−1.30 SD; 10th) ND 4,030 (+1.32 SD; 91th) 3,200 (−0.58 SD; 28th) 3,370 (−0.11 SD; 46th) 1/16
Body length at birth (cm) (SD) ND ND 50 (−0.06 SD; 48th) 58 (+3.1 SD; > 99th) ND 49 (−0.44 SD; 33th) ND 56 (+2.38 SD; 99th) 49 (−0.44 SD; 33th) ND 2/7
OFC (cm) (centile) ND ND 37 (+0.68 SD; 75th) 39 (+1.92 SD; 97th) 37 (+1.22SD; 89th) 34 (−0.83 SD; 20th) ND 37 (+1.22 SD; 89th) ND ND 1/8

Postnatal Growth >2 SDS

Height (cm) (SD) 122.6 (+1.46 SD; 93th) 131 (+0.56 SD; 71th) 131 (+1.70 SD; 96th) 165 (+0.27 SD; 61th) 92 (−0.68 SD; 25th) 131.5 (+0.62 SD; 73th) 177.8 (−0.17 SD; 57th) 137 (+2.68 SD; >99th) 144 (+0.80 SD; 79th) (75 centile) 3/16
Weight (kg) 26.2 (+1.32 SD; 91th) 28.9 (+0.49 SD; 69th) 22 (−0.41 SD; 34th) 68.5 (+0.68 SD; 75th) 18.9 (+2.36 SD; 99th) 25.5 (−0.04 SD; 48th) ND 43.9 (+3.82 SD; >99th) 41 (+0.99 SD; 84th) (50–75 centile) 3/15
OFC (cm) (SD) 55.6 (+3.35 SD; >99th) 55.2 (+2.71 SD; >99th) 55 (+2.17 SD; 99th) 61 (+6.01; >99th) 55.5 (+4.60 SD; >99th) 52.5 (+0.15 SD; 56th) 61.5 (+4.46 SD; >99th) 57 (+4.39 SD; >99th) 54.5 (+1.19 SD; 88th) (50–75 centile) 13/16

Neurodevelopmental Characteristics

Muscular hypotonia N N Y Y Y N N Y Y Y 11/17
Motor delay ND ND Y Y Y N Y N Y N 11/16
Speech delay Y Y Y Y Y Y Y Y Y Y 18/18
Intellectual disability learning disability (not formally tested) borderline mild ID learning disability mild mild mild learning disability mild mild learning disability 18/18
Attention deficit Y Y Y Y NA Y Y Y Y Y 11/15
Behavioral anomalies reactive attachment disorder, passive, pleasing autistic features, social difficulties N short temper NA anxiety, hetero-agressivity ASD, impulse control problems, trouble gauging emotions Y ASD and psychotic episodes Y 13/15
Seizures N N N N N N N N N N 0/18
Neurological deficits N N N ND ND N insensitivity to pain, temperature dysregulation N N N 2/14

Brain MRI Findings 9/11

Corpus callosum anomaly ND N N ND ND ND complete agenesis complete agenesis N ND 5/11
Ventriculomegaly ND N N ND ND ND Y N N ND 2/11
Other ND slight asymmetric hemispheres NA ND ND ND moderately decreased white matter volume; bilateral probst bundles mildely decreased white matter volume NA ND 7/11

Internal Malformations 7/17

Genitourinary system N N N N N ND N N cryptorchidism N 2/17
Gastrointestinal system N N N N N ND N N N N 0/17
Heart small VSD narrow pulmonary artery, normalized at 2 y N N PDA ND N N N bicuspid aortic valve 5/17
Other malformations N N N N N NA N N N N 0/17

Abbreviations: Y, trait present; N, trait absent; ND, not determined; NA, not applicable; ID, intellectual disability; SD, standard deviation; gw, weeks of gestation.